Colman Rachel, Hussain Abdullah, Goodall Margaret, Young Steven P, Pankhurst Tanya, Lu Xiaomei, Jefferis Royston, Savage Caroline O S, Williams Julie M
Wellcome Trust Clinical Research Facility, University Hospital Birmingham Foundation Trust, Queen Elizabeth Hospital, Birmingham, UK.
Ann Rheum Dis. 2007 May;66(5):676-82. doi: 10.1136/ard.2006.061374. Epub 2007 Jan 4.
Antineutrophil cytoplasmic antibodies (ANCA) are associated with small-vessel vasculitis and have been implicated in its pathogenesis. The subclass distribution of ANCA IgG deviates from normal patterns, and it has been suggested that the IgG3 subclass may have pathogenic potential over the IgG1 subclass and may be more likely to be associated with active disease and renal involvement.
To deal with potential pathogenicity, chimeric antibodies were constructed of IgG1 and three subclasses with human IgG1 or three constant regions and a murine-derived variable region that binds an epitope within the ANCA antigen proteinase 3 (PR3) that is recognised by human autoantibodies.
The antibodies were characterised for binding to PR3, including affinity and avidity, before being used as tools to explore their ability to activate human neutrophils for superoxide release, cytokine release, degranulation and ability to induce neutrophil adhesion under flow.
Both subclass antibodies elicited similar neutrophil responses for superoxide release, degranulation and interleukin (IL) 8 production, although quantitative responses showed that the IgG1 subclass favoured degranulation and the IgG3 subclass favoured IL8 production. Both antibodies were able to convert neutrophils from selectin-dependent rolling adhesion to integrin-dependent stationary adhesion in a flow assay.
These findings indicate that humanised antibodies directed against a single epitope of PR3 can recapitulate the effects of polyclonal human ANCA, which recognises multiple PR3 epitopes. Further, PR3-ANCA of both IgG1 and IgG3 subclasses can activate neutrophils, although the more potent IL8 response by IgG3 PR3-ANCA may encourage further neutrophil recruitment and amplify injury.
抗中性粒细胞胞浆抗体(ANCA)与小血管炎相关,并参与其发病机制。ANCA IgG的亚类分布偏离正常模式,有人提出IgG3亚类可能比IgG1亚类具有更强的致病潜力,并且更可能与活动性疾病和肾脏受累相关。
为研究潜在的致病性,构建了嵌合抗体,其由IgG1和三个亚类组成,具有人IgG1或三个恒定区以及与ANCA抗原蛋白酶3(PR3)内一个表位结合的鼠源可变区,该表位可被人自身抗体识别。
在用作工具探索其激活人中性粒细胞释放超氧化物、释放细胞因子、脱颗粒的能力以及在流动状态下诱导中性粒细胞黏附的能力之前,对抗体与PR3的结合特性进行了表征,包括亲和力和avidity(亲和力常数,此处保留英文未译,可能是专业术语)。
两种亚类抗体在超氧化物释放、脱颗粒和白细胞介素(IL)-8产生方面引发了相似的中性粒细胞反应,尽管定量反应表明IgG1亚类更倾向于脱颗粒,而IgG3亚类更倾向于IL-8产生。在流动试验中,两种抗体都能够使中性粒细胞从选择素依赖性滚动黏附转变为整合素依赖性静止黏附。
这些发现表明,针对PR3单一表位的人源化抗体可以重现多克隆人ANCA的作用,多克隆人ANCA可识别多个PR3表位。此外,IgG1和IgG3亚类的PR3-ANCA均可激活中性粒细胞,尽管IgG3 PR3-ANCA更强的IL-8反应可能会促进更多中性粒细胞的募集并加剧损伤。